Biblio
3D Bioprinted Drug-Resistant Breast Cancer Spheroids for Quantitative in situ Evaluation of Drug Resistance. Acta Biomater. 2021.
. High-Resolution In Situ High-Content Imaging of 3D-Bioprinted Single Breast Cancer Spheroids for Advanced Quantification of Benzo()pyrene Carcinogen-Induced Breast Cancer Stem Cells. ACS Appl Mater Interfaces. 2023.
. Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)] co-targeting drug resistant GRP78 and subcellular organelles in cancer stem cells. Eur J Med Chem. 2018;156:747-759.
. .